Sell biopharma stock Amgen ahead of its obesity drug update, Barclays says
The bank said the biopharma company will have to surpass high expectations after its stock move this month.
LocalNews
0
12
The bank said the biopharma company will have to surpass high expectations after its stock move this month.
